In vitro antiproliferative and cytotoxic activities of novel triphenyltin isoselenocyanate in human breast carcinoma cell lines MCF 7 and MDA-MB-231

被引:0
作者
Luba Hunakova
Eva Horvathova
Miroslava Matuskova
Pavel Bobal
Jan Otevrel
Julius Brtko
机构
[1] Comenius University,Institute of Immunology, Faculty of Medicine
[2] Slovak Academy of Sciences,Biomedical Research Center, Cancer Research Institute
[3] Masaryk University,Department of Chemical Drugs, Faculty of Pharmacy
[4] Slovak Academy of Sciences,Institute of Experimental Endocrinology, Biomedical Research Center
来源
Medical Oncology | / 39卷
关键词
Apoptosis; Breast cancer; Cytotoxicity; DNA crosslinks; Migration; Triorganotin isoselenocyanates;
D O I
暂无
中图分类号
学科分类号
摘要
Intensive investigation for novel antiproliferative and cytotoxic effective chemical compounds is currently concentrated on structurally modified agents of natural or synthetic source. The selenium derivative of triorganotin compound, triphenyltin isoselenocyanate (TPT-NCSe) caused higher cytotoxicity in hormone sensitive MCF 7 (IC 50–250 nM) in comparison with triple-negative MDA-MB-231 breast carcinoma cell line (IC 50–450 nM) as determined by MTT assay. Measurement of DNA damage showed presence of crosslinks in both cell lines treated by increasing TPT-NCSe concentrations. This compound decreased mitochondrial membrane potential shown by JC-1 staining in a concentration-dependent manner in both cell lines. Activation of caspases-3/7 was observed in MDA-MB-231 cells and was significant only by concentrations causing significant level of crosslinks. On the other hand, migration assay revealed inhibitory effect of viability keeping 100 nM concentration of TPT-NCSe on migration of MDA-MB-231 cells. Our data has shown that this selenium containing triorganotin molecule exerts DNA damage-linked antineoplastic activity in breast carcinoma cell lines studied.
引用
收藏
相关论文
共 150 条
[1]  
Annageldiyev C(2020)The PI3K/AKT pathway inhibitor ISC-4 induces apoptosis and inhibits growth of leukemia in preclinical models of acute myeloid leukemia Front Oncol 10 393-R707
[2]  
Tan SF(2005)Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells Breast Cancer Res 7 R699-197
[3]  
Thakur S(2004)Mechanisms of mammary cancer chemoprevention by organoselenium compounds Mutat Res 551 181-28
[4]  
Dhanyamraju PK(2004)Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds Curr Cancer Drug Targets 4 13-5275
[5]  
Ramisetti SR(2019)Development of isoselenocyanate compounds’ syntheses and biological applications J Med Chem 62 5261-192
[6]  
Bhadauria P(1998)Chemopreventive agents: selenium Pharmacol Ther 79 179-49
[7]  
Schick J(2001)Molecular mechanisms of cancer prevention by selenium compounds Nutr Cancer 40 42-28
[8]  
Zeng Z(2004)Selenium and its relationship to cancer: an update Br J Nutr 91 11-1473
[9]  
Sharma V(2000) effects of Se-allylselenocysteine and Se-propylselenocysteine on cell growth, DNA integrity, and apoptosis Biochem Pharmacol 60 1467-867
[10]  
Dunton W(2001)Methylselenocysteine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland Anticancer Res 21 863-1535